The HIV and COVID-19 Global Pandemics - Lessons for Responding to Both Viruses

Explore the parallels between the HIV and COVID-19 global pandemics in this insightful Melbourne University Chemical Society lecture delivered by Professor Sharon Lewin AO, Director of the Peter Doherty Institute for Infection Control and Immunity. Delve into the history of emerging infectious diseases, the evolution of HIV treatment, and the ongoing quest for an HIV cure. Examine cutting-edge approaches such as latency reversal, cancer immunotherapy applications, and gene therapy in HIV research. Investigate the Doherty Institute's pandemic response, non-pharmaceutical interventions for COVID-19, and the importance of understanding super-spreading events. Learn about the latest developments in COVID-19 therapeutics, including antibody treatments and combination antivirals. Gain valuable insights into novel antiviral approaches and the lessons learned from both pandemics that can inform future global health strategies.

Intro
MUCS 100 years ago
Global emerging infectious diseases: 1980s
HIV treatment in 1996 and 2020
Why we need a cure for HIV
Latency reversal: shock and kill
Multiple latency reversal agents active in vitro
Cancer immunotherapy: lessons for HIV cure
Gene therapy for HIV: another path to a cure?
Gene therapy: ex vivo gene modification
The Doherty Institute: built for a pandemic respe
Non pharmaceutical interventions: can they be refine
Super spreading events are key to spread of COVID
Therapeutics for COVID-19: treating earlier
SARS COV2 antibodies: a new therapeutic for COVID
Combination antivirals for SARS COV2
ASCOT: A randomised adaptive platform trial
Novel antiviral approaches: gene therapy CRISPR Ca
HIV and COVID-19: lessons for success